Collision of basic and applied approaches to risk assessment of thyroid toxicants

Annals of the New York Academy of Sciences

Volumn 1076, Issue , 2006, Pages 168-190

  Zoeller, R Thomas ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Brain development; PCB; Perchlorate; Thyroid hormone; Thyroid receptors

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AMMONIUM PERCHLORATE; PERCHLORATE; POLYCHLORINATED BIPHENYL; THYROID HORMONE; THYROID HORMONE RECEPTOR;

BRAIN DEVELOPMENT; CHEMICAL REACTION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DISEASE PREDISPOSITION; FETUS OUTCOME; GROUPS BY AGE; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; NEUROTOXICITY; NONHUMAN; PROTEIN INTERACTION; RISK ASSESSMENT; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE METABOLISM;

EID: 33845619484     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1371.077     Document Type: Conference Paper

References (179)

1. JACOBSEN, B.B. & N.J. BRANDT. 1981. Congenital hypothyroidism in Denmark: incidence, types of thyroid disorders and age at onset of therapy in children: 1970-1975. Arch Dis Child. 56: 134-136.
2. ALM, J. et al. 1984. Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br. Med. J. 289: 1171-1175.
3. KLEIN, R. 1980. History of congenital hypothyroidism. In Neonatal Thyroid Screening. G.N. Burrow & J.H. Dussault, Eds.: 51-59. Raven Press. New York.
4. KLEIN, R.Z. & M.L. MITCHELL. 1996. Neonatal Screening for Hypothyroidism. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 984-988. Lipponcott-Raven. Philadelphia.
5. CHAN, S. & M.D. KILBY. 2000. Thyroid hormone and central nervous system development. J. Endocrinol. 165: 1-8.
6. KILBY, M.D. et al. 2000. Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol. (Oxf.) 53: 469-477.
7. CHAN, S. et al. 2002. Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex. Brain Res. Dev. Brain Res. 138: 109-116.
8. KILBY, M.D. 2003. Thyroid hormones and fetal brain development. Clin. Endocrinol (Oxf). 59: 280-281.
9. BRADLEY, D.J., H.C. TOWLE & W.S. YOUNG. 1992. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta-2 subtype, in the developing mammalian nervous system. J. Neurosci. 12: 2288-2302.
10. ANDERSEN, S. et al. 2002. Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87: 1068-1072.
11. SPENCER, C.A. 2000. Thyroglobulin. In Werner and Ingbar's The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 402-413. Lippincott Williams and Wilkins. Philadelphia, PA.
12. TAUROG, A. 2004. Hormone synthesis: thyroid iodine metabolism. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 61-85. Lippincott-Raven. Philadelphia.
13. LEONARD, J.L. & J. KOEHRLE. 1996. Intracellular pathways of iodothyronine metabolism. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 125-161. Lippincott-Raven. Philadelphia.
14. SPAULDING, S.W. 2000. Biological actions of thyrotropin. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 227-233. Lippincott Williams and Wilkins. Philadelphia.
15. STOCKIGT, J.R. 2000. Serum thyrotropin and thyroid hormone measurements and assessment of thyroid hormone transport. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 376-392. Lippincott-Raven. Philadelphia.
16. MORLEY, J.E. 1981. Neuroendocrine control of thyrotropin secretion. Endocrine Rev. 2: 396-436.
17. SCANLON, M.F. & A.D. TOFT. 2000. Regulation of Thyrotropin Secretion. In The Thyroid: a Fundamental and Clinical Text, 8th Edition. L.E. Braverman & R.D. Utiger, Eds.: 234-253. Lippincott William & Wilkins. Philadelphia.
18. KOLLER, K.J. et al. 1987. Thyroid hormones regulate levels of thyrotropin-releasing hormone mRNA in the paraventricular nucleus. Proc. Natl. Acad. Sci. USA. 84: 7329-7333.
19. RONDEEL, J.M.M. et al. 1989. In vivo hypothalamic release of thyrotropin-releasing hormone after electrical stimulation of the paraventricular area: comparison between push-pull perfusion technique and collection of hypophysial portal blood. Endocrinology 125: 971-975.
20. GREER, M.A. et al. 1993. Evidence that the major physiological role of TRH in the hypothalamic paraventricular nuclei may be to regulate the set-point for thyroid hormone negative feedback on the pituitary thyrotroph. Neuroendocrinology. 57: 569-575.
21. TAYLOR, T. et al. 1990. The paraventricular nucleus of the hypothalamus has a major role in thyroid hormone feedback regulation of thyrotropin synthesis and secretion. Endocrinology 126: 317-324.
22. ST. GERMAIN, D.L. & V.A. GALTON. 1997. The deiodinase family of selenoproteins. Thyroid 7: 655-668.
23. NISHII, Y. et al. 1993. Induction of cytosolic triiodo-L-thyronine (T3) binding protein (CTBP) by T3 in primary cultured rat hepatocytes. Endocr. J. 40: 399-404.
24. MORI, J. et al. 2002. Nicotinamide adenine dinucleotide phosphate-dependent cytosolic T(3) binding protein as a regulator for T(3)-mediated transactivation. Endocrinology 143: 1538-1544.
25. BERNAL, J., A. GUADANO-FERRAZ & B. MORTE. 2003. Perspectives in the study of thyroid hormone action on brain development and function. Thyroid. 13: 1005-1012.
26. BERNAL, J. 2005. The significance of thyroid hormone transporters in the brain. Endocrinology. 146: 1698-1700.
27. HEUER, H. et al. 2005. The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146: 1701-1706.
28. BRAVERMAN, L.E. et al. 2005. The effect of perchlorate, thiocyanate, and nitrate on thyroid function in workers exposed to perchlorate long-term. J. Clin. Endocrinol. Metab. 90: 700-706.
29. MESTMAN, J.H. 1999. Diagnosis and management of maternal and fetal thyroid disorders. Curr. Opin. Obstet. Gynecol. 11: 167-175.
30. BURMEISTER, L.A., J. PACHUCKI & D.L. ST. GERMAIN. 1997. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138: 5231-5237.
31. EPA, U. S. 1998. Perchlorate environmental contamination: toxicological review and risk characterization based on emerging information. http://www.epa.gov/ncea/perch.htm.
32. EPA, U.S. 1999. Perchlorate. http://www.epa.gov/OGWDW/ccl/perchlor/ perchlo.html.
33. URBANSKY, E.T. 1998. Perchlorate chemistry: implications for analysis and remediation. Bioremed. J. 2: 81-95.
34. WOLFF, J. 1998. Perchlorate and the thyroid gland. Pharmacol. Rev. 50: 89-105.
35. GREER, M.A. et al. 2002. Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Environ. Health Perspect. 110: 927-937.
36. VULSMA, T. 1991. Etiology and Pathogenesis of Congenital Hypothyroidism. Evaluation and Examination of Patients Detected by Neonatal Screening in the Netherlands. Academisch Proefschrift, Amsterdam.
37. VAN DEN HOVE, M.F. et al. 1999. Hormone synthesis and storage in the thyroid of human preterm and term newborns: effect of thyroxine treatment. Biochimie. 81: 563-570.
38. SAVIN, S. et al. 2003. Thyroid hormone synthesis and storage in the thyroid gland of human neonates. J. Pediatr. Endocrinol. Metab. 16: 521-528.
39. SPITZWEG, C. et al. 1998. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab. 83: 1746-1751.
40. RILLEMA, J.A. & D.L. ROWADY. 1997. Characteristics of the prolactin stimulation of iodide uptake into mouse mammary gland explants. Proc. Soc. Exp. Biol. Med. 215: 366-369.
41. RILLEMA, J.A., T.X. YU & S.M. JHIANG. 2000. Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants. Am. J. Physiol. Endocrinol. Metab. 279: E769-772.
42. PERRON, B. et al. 2001. Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J. Endocrinol. 170: 185-196.
43. HOWARD, B.J. et al. 1996. A review of countermeasures to reduce radioiodine in milk of dairy animals. Health Physics. 71: 661-673.
44. MOUNTFORD, P.J. et al. 1986. Transfer of radioiodide to milk and its inhibition. Nature 322: 600.
45. KIRK, A.B. et al. 2005. Perchlorate and Iodide in dairy and breast milk. Environ. Sci. Technol. 39: 2011-2017
46. VAN VLIET, G. 1999. Neonatal hypothyroidism: Treatment Outcome. Thyroid 9: 79-84.
47. NAS. 2005. Health Implications of Perchlorate Ingestion.
48. HEYERDAHL, S., F.B. KASE & S.O. LIE. 1991. Intellectual development in children with congenital hypothyroidism is relation to recommended thyroxine treatment. J. Pediatr. 118: 850-857.
49. HEYERDAHL, S. 2001. Longterm outcome in children with congenital hypothyroidism. Acta. Paediatr. 90: 1220-1222.
50. HEYERDAHL, S. & B. OERBECK. 2003. Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid 13: 1029-1038.
51. OERBECK, B. et al. 2003. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics. 112: 923-930.
52. FIELDS, C., M. DOURSON & J. BORAK. 2005. Iodine-deficient vegetarians: a hypothetical perchlorate-susceptible population? Regul. Toxicol. Pharmacol. 42: 37-46.
53. CRUMP, K.S. & J.P. GIBBS. 2005. Benchmark calculations for perchlorate from three human cohorts. Environ. Health Perspect. 113: 1001-1008.
54. GINSBERG, G. & D. RICE. 2005. The NAS Perchlorate Review: questions remain about the perchlorate RfD. Environ. Health Perspect. 113: 1117-1119.
55. MCKINNEY, J.D. & C.L. WALLER. 1994. Polychlorinated biphenyls as hormonally active structural analogues. Environ. Health Perspect. 102: 290-297.
56. MCKINNEY, J.D. & C.L. WALLER. 1998. Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. J. Toxicol. Environ. Health B. Crit. Rev. 1: 27-58.
57. CHANA, A. et al. 2002. Computational studies on biphenyl derivatives. Analysis of the conformational mobility, molecular electrostatic potential, and dipole moment of chlorinated biphenyl: searching for the rationalization of the selective toxicity of polychlorinated biphenyls (PCBs). Chem. Res. Toxicol. 15: 1514-1526.
58. BREIVIK, K. et al. 2002. Towards a global historical emission inventory for selected PCB congeners - a mass balance approach. 1. Global production and consumption. Sci. Total. Environ. 290: 181-198.
59. FISHER, B.E. 1999. Most unwanted. Environ. Health Perspect. 107: A18-23.
60. HUISMAN, M. et al. 1995. Neurological condition in 18-month-old children perinatally exposed to polychlorinated biphenyls and dioxins. Early Hum.f Dev. 43: 165-176.
61. JACKSON, T.A. et al. 1997. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11: 693-705.
62. OSIUS, N. et al. 1999. Exposure to polychlorinated biphenyls and levels of thyroid hormones in children. Environ. Health Perspect. 107: 843-849.
63. KORRICK, S.A. & L. ALTSHUL. 1998. High breast milk levels of polychlorinated biphenyls (PCBs) among four women living adjacent to a PCB-contaminated waste site. Environ. Health Perspect. 106: 513-518.
64. AYOTTE, P. et al. 2003. Assessment of pre- and postnatal exposure to polychlorinated biphenyls: lessons from the inuit cohort study. Environ. Health Perspect. 111: 1253-1258.
65. WALKOWIAK, J. et al. 2001. Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood. Lancet 358: 1602-1607.
66. STEWART, P. et al. 2003. Prenatal PCB exposure, the corpus callosum, and response inhibition. Environ. Health Perspect. 111: 1670-1677.
67. STEWART, P. et al. 2005. Response inhibition at 8 and 9 1/2 years of age in children prenatally exposed to PCBs. Neurotoxicol. Teratol. 27: 771-780.
68. ZOELLER, R.T. A.L. DOWLING & A.A. VAS. 2000. Developmental exposure to polychlorinated biphenyls exerts thyroid hormone-like effects on the expression of RC3/neurogranin and myelin basic protein messenger ribonucleic acids in the developing rat brain. Endocrinol. 141: 181-189.
69. GOLDEY, E.S. et al. 1995. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol. Appl. Pharmacol. 135: 77-88.
70. BASTOMSKY, C.H. 1977. Goitres in rats fed polychlorinated biphenyls. Can. J. Physiol. Pharmacol. 55: 288-292.
71. BASTOMSKY, C.H. 1977. Enhanced thyroxine metabolism and high uptake goiters in rats after a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Endocrinology. 101: 292-296.
72. BASTOMSKY, C.H., P.V.N. MURTHY & K. BANOVAC. 1976. Alterations in thyroxine metabolism produced by cutaneous application of microscope immersion oil: effects due to polychlorinated biphenyls. Endocrinology. 98: 1309-1314.
73. CROFTON, K.M. 2004. Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats. Risk Anal. 24: 1665-1671.
74. CROFTON, K.M. et al. 2000. PCBs, thyroid hormones, and ototoxicity in rats: cross-fostering experiments demonstrate the impact of postnatal lactation exposure. Toxicol. Sci. 57: 131-140.
75. BROUWER, A. et al. 1999. Characterization of potential endocrine-related health effects at low- dose levels of exposure to PCBs. Environ. Health Perspect. 107 (Suppl 4): 639-649.
76. GOLDEY, E.S. & K.M. CROFTON. 1998. Thyroxine replacement attenuates hypothyroxinemia, hearing loss, and motor deficits following developmental exposure to Aroclor 1254 in rats. Toxicol. Sci. 45: 94-105.
77. KOIBUCHI, N. & W.W. CHIN. 2000. Thyroid hormone action and brain development. Trend. Endocrinol. Metab. 11: 123-128.
78. LI, G.H. et al. 2004. Impact of thyroid hormone deficiency on the developing CNS: cerebellar glial and neuronal protein expression in rat neonates exposed to antithyroid drug propylthiouracil. Cerebellum 3: 100-106.
79. YOUSEFI, B. et al. 2005. Postnatal changes of steroid receptor coactivator-1 immunoreactivity in rat cerebellar cortex. Thyroid 15: 314-319.
80. ROEGGE, C.S. et al. 2004. Motor impairment in rats exposed to PCBs and methylmercury during early development. Toxicol. Sci. 77: 315-324.
81. NGUON, K., M.G. BAXTER & E.M. SAJDEL-SULKOWSKA. 2005. Perinatal exposure to polychlorinated biphenyls differentially affects cerebellar development and motor functions in male and female rat neonates. Cerebellum 4: 112-122.
82. GRANHOLM, A.C. 1985. Effects of thyroid hormone deficiency on glial constituents in developing cerebellum of the rat. Exp. Brain Res. 59: 451-456.
83. TRAGGIAI, C. & R. STANHOPE. 2004. Body mass index and hypothalamic morphology on MRI in children with congenital midline cerebral abnormalities. J. Pediatr. Endocrinol. Metab. 17: 219-221.
84. SCHOONOVER, C.M. et al. 2004. Thyroid hormone regulates oligodendrocyte accumulation in developing rat brain white matter tracts. Endocrinology 145: 5013-5020.
85. BERBEL, P. et al. 1994. Role of thyroid hormones in the maturation of interhemispheric connections in rats. Behav. Brain. Res. 64: 9-14.
86. GAUGER, K.J. et al. 2004. Polychlorinated biphenyls (PCBs) exert thyroid hormone-like effects in the fetal rat brain but do not bind to thyroid hormone receptors. Environ. Health Perspect. 112: 516-523.
87. BANSAL, R. et al. 2005. Maternal thyroid hormone increases HES expression in the fetal rat brain: An effect mimicked by exposure to a mixture of polychlorinated biphenyls (PCBs). Brain Res. Dev. Brain Res. 156: 13-22.
88. KITAMURA, S. et al. 2005. Thyroid hormone-like and estrogenic activity of hydroxylated PCBs in cell culture. Toxicology 208: 377-387.
89. FRITSCHE, E. et al. 2005. Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environ. Health Perspect. 113: 871-876.
90. ARULMOZHIRAJA, S. & M. MORITA. 2004. Structure-activity relationships for the toxicity of polychlorinated dibenzofurans: approach through density functional theory-based descriptors. Chem. Res. Toxicol. 17: 348-356.
91. KIMURA-KURODA, J., I. NAGATA & Y. KURODA. 2005. Hydroxylated metabolites of polychlorinated biphenyls inhibit thyroid-hormone-dependent extension of cerebellar Purkinje cell dendrites. Brain Res. Dev. Brain Res. 154: 259-263.
92. BOGAZZI, F. et al. 2003. Effects of a mixture of polychlorinated biphenyls (Aroclor 1254) on the transcriptional activity of thyroid hormone receptor. J. Endocrinol. Invest. 26: 972-978.
93. IWASAKI, T. et al. 2002. Polychlorinated biphenyls suppress thyroid hormone-induced transactivation. Biochem. Biophys. Res. Commun. 299: 384-388.
94. MIYAZAKI, W. et al. 2004. Polychlorinated biphenyls suppress thyroid hormone receptor-mediated transcription through a novel mechanism. J. Biol. Chem. 279: 18195-18202.
95. KATO, Y. et al. 1998. Reduction of thyroid hormone levels by methylsulfonyl metabolites of polychlorinated biphenyl congeners in rats. Arch. Toxicol. 72: 541-554.
96. REPORTER, C.M. 1999. ChemExpo Chemical Profile: Bisphenol-A. Schnell Publishing Company. Sutton, England.
97. HOWE, S.R., L. BORODINSKY & R.S. LYON. 1998. Potential exposure to bisphenol A from food-contact use of epoxy coated cans. J. Coatings Technology 70: 69-74.
98. LEWIS, J.B. et al. 1999. Identification and characterization of estrogen-like components in commercial resin-based dental restorative materials. Clin. Oral Investig. 3: 107-113.
99. SCHONFELDER, G. et al. 2002. Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 110: A703-A707.
100. IKEZUKI, Y. et al. 2002. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 17: 2839-2841.
101. WHO, E. H. C. 1995. Tetrabromobisphenol A and derivatives. World Health Organization. Brussels, Belgium.
102. WHO, E. H. C. 1997. Flame-retardants: a general introduction. World Health Organization. Brussels, Belgium.
103. THOMSEN, C., E. LUNDANES & G. BECHER. 2002. Brominated flame retardants in archived serum samples from Norway: a study on temporal trends and the role of age. Environ. Sci. Technol. 36: 1414-1418.
104. MORIYAMA, K. et al. 2002. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 87: 5185-5190.
105. STAPLES, C.A. et al. 1998. A review of the environmental fate, effects, and exposures of bisphenol A. Chemosphere 36: 2149-2173.
106. KRISHNAN, A. V. et al. 1993. Bisphenol A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132: 2279-2286.
107. GAIDO, K. W. et al. 1997. Evaluation of chemicals with endocrine modulating activity in yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143: 205-212.
108. KITAMURA, S. et al. 2002. Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A. Biochem. Biophys. Res. Commun. 293: 554-559.
109. MORIYAMA, K. et al. 2002. Thyroid hormone action is dusrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 87: 5185-5190.
110. CHENG, S.Y. 2005. Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance. Trends Endocrinol. Metab. 16: 176-182.
111. ZOELLER, R.T., R. BANSAL & C. PARRIS. 2005. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 146: 607-612.
112. SEIWA, C. et al. 2004. Bisphenol A exerts thyroid-hormone-like effects on mouse oligodendrocyte precursor cells. Neuroendocrinology 80: 21-30.
113. ISHIDO, M. et al. 2004. Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J. Neurosci. Res. 76: 423-433.
114. REFETOFF, S. et al. 1994. The syndromes of resistance to thyroid hormone: update 1994. In Clinical and Molecular Aspects of Diseases of the Thyroid, Vol. 3. L.E. Braverman & S. Refetoff, Eds.: 336-343. Endocrine Society. Bethesda, MD.
115. TOGASHI, M. et al. 2005. Rearrangements in thyroid hormone receptor charge clusters that stabilize bound 3,5′,5-triiodo-L-thyronine and inhibit homodimer formation. J. Biol. Chem. 280: 25665-25673.
116. DOWLING, A.L.S. et al. 2000. Acute changes in maternal thyroid hormone induce rapid and transient changes in specific gene expression in fetal rat brain. J. Neurosci. 20: 2255-2265.
117. DOWLING, A.L.S., E.A. IANNACONE & R.T. ZOELLER. 2001. Maternal hypothyroidism selectively affects the expression of neuroendocrine-specific protein-A messenger ribonucleic acid in the proliferative zone of the fetal rat brain cortex. Endocrinology 142: 390-399.
118. DOWLING, A.L.S. & R.T. ZOELLER. 2000. Thyroid hormone of maternal origin regulates the expression of RC3/Neurogranin mRNA in the fetal rat brain. Brain Res. 82: 126-132.
119. WU, Y. et al. 2003. Hes1 but not Hes5 regulates an astrocyte versus oligodendrocyte fate choice in glial restricted precursors. Dev. Dyn. 226: 675-689.
120. SCHUURMANS, C. & F. GUILLEMOT. 2002. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr. Opin. Neurobiol. 12: 26-34.
121. GAIANO, N. & G. FISHELL. 2002. The role of notch in promoting glial and neural stem cell fates. Annu. Rev. Neurosci. 25: 471-490.
122. SHARLIN, D.S., R. BANSAL & R.T. ZOELLER. 2006. Polychlorinated biphenyls exert selective effects on cellular composition of white matter in a manner inconsistent with thyroid hormone insufficiency. Endocrinology 147: 846-858.
123. SEGERSEN, T.P. et al. 1987. Localization of thyrotropin-releasing hormone pro-hormone messenger ribonucleic acid in rat brain by in situ hybridization. Endocrinology 121: 98-107.
124. SEGERSEN, T.P. et al. 1987. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science 238: 78-80.
125. LECHAN, R.M., P. WU & I.M.D. JACKSON. 1986. Immunolocalization of the thyrotropin-releasing hormone prohormone in the rat central nervous system. Endocrinology 119: 1210-1216.
126. JACKSON, I.M.D., P. WU & R.M. LECHAN. 1985. Immunohistochemical localization in the rat brain of the precursor for thyrotropin releasing hormone. Science 229: 1097-1099.
127. ISHIKAWA, K. et al. 1988. Immunocytochemical delineation of the thyrotrophic area: origin of thyrotropin-releasing hormone in the median eminence. Neuroendocrinology 47: 384-388.
128. MERCHENTHALER, I. & Z. LIPOSITS. 1994. Mapping of thyrotropin-releasing hormone (TRH) neuronal systems of rat forebrain projecting to the median eminence and the OVLT Immunocytochemistry combined with retrograde labeling at the light and electron microscopic levels. Acta. Biol. Hung. 45: 361-374.
129. MARTIN, J.B. & S. REICHLIN. 1987. Clinical Neuroendocrinology. F.A. Davis Company. Philadelphia, PA.
130. AIZAWA, T. & M.A. GREER. 1981. Delineation of the hypothalamic area controlling thyrotropin secretion in the rat. Endocrinology 109: 1731-1738.
131. HAISENLEDER, D.J. et al. 1992. Differential actions of thyrotropin (TSH)-releasing hormone pulses in the expression of prolactin and TSH subunit messenger ribonucleic acid in rat pituitary cells in vitro. Endocrinology 130: 2917-2923.
132. HAREL, G. et al. 1993. Effect of thyroid hormone deficiency on glycosylation of rat TSH secreted in vitro. Horm. Metab. Res. 25: 278-280.
133. LIPPMAN, S.S., S. AMR & B.D. WEINTRAUB. 1986. Discordant effects of thyrotropin (TSH)-releasing hormone on pre- and posttranslational regulation of TSH biosynthesis in rat pituitary. Endocrinology 119: 343-348.
134. MAGNER, J.A., J. KANE & E.T. CHOU. 1992. Intravenous thyrotropin (TSH)-releasing hormone releases human TSH that is structurally different from basal TSH. J. Clin. Endocrinol. Metab. 74: 1306-1311.
135. TAYLOR, T. & B.D. WEINTRAUB. 1985. Thyrotropin (TSH)-releasing hormone regulation of TSH subunit biosynthesis and glycosylation in normal and hypothyroid rat pituitaries. Endocrinology 116: 1968-1976.
136. TAYLOR, T., N. GESUNDHEIT & B.D. WEINTRAUB. 1986. Effects of in vivo bolus versus continuous TRH administration on TSH secretion, biosynthesis, and glycosylation in normal and hypothyroid rats. Mol. Cell. Endocrinol. 46: 253-261.
137. WEINTRAUB, B.D. et al. 1989. Effect of TRH on TSH glycosylation and biological action. Ann N. Y. Acad. Sci. 553: 205-213.
138. NIKRODHANOND, A.A. et al. 2006. Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J. Biol. Chem. 281: 5000-5007.
139. WONDISFORD, F.E., J.A. MAGNER & B.D. WEINTRAUB. 1996. Chemistry and biosynthesis of thyrotropin. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 190-206. Lippincott and Raven. Philadelphia, PA.
140. HADLEY, M.E. 2000. Endocrinology. Prentice Hall. Upper Saddle River, NJ.
141. WONDISFORD, F.E., J.A. MAGNER & B.D. WEINTRAUB. 1996. Thyrotropin. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. Utiger, Eds.: 190-206. Lippincott-Raven. Philadelphia, PA.
142. TAUROG, A., M.L. DORRIS & D.R. DOERGE. 1996. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. Thyroid. 6: 211-219.
143. PRUMMEL, M.F. et al. 2000. Expression of the thyroid-stimulating hormone receptor in the folliculo-stellate cells of the human anterior pituitary. J. Clin. Endocrinol. Metab. 85: 4347-4353.
144. THEODOROPOULOU, M. et al. 2000. Thyrotrophin receptor protein expression in normal and adenomatous human pituitary. J. Endocrinol. 167: 7-13.
145. PRUMMEL, M.F., L.J. BROKKEN & W.M. WIERSINGA. 2004. Ultra short-loop feedback control of thyrotropin secretion. Thyroid 14: 825-829.
146. SCHUSSLER, G.C. 2000. The thyroxine-binding proteins. Thyroid 10: 141-149.
147. FINK, I.L. et al. 1986. Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA: close homology to the serine antiproteases. Proc. Natl. Acad. Sci. USA. 83: 7708-7712.
148. JANSSEN, O.E. et al. 2002. Characterization of T(4)-binding globulin cleaved by human leukocyte elastase. J. Clin. Endocrinol. Metab. 87: 1217-1222.
149. GRASBERGER, H. et al. 2002. Loop variants of the serpin thyroxine-binding globulin: implications for hormone release upon limited proteolysis. Biochem. J. 365: 311-316.
150. VRANCKX, R. et al. 1990. The hepatic biosynthesis of rat thyroxine binding globulin (TBG): demonstration, ontogenesis, and up-regulation in experimental hypothyroidism. Biochem. Biophys. Res. Commun. 167: 317-322.
151. VRANCKX, R. et al. 1994. Regulation of rat thyroxine-binding globulin and transthyretin: studies in thyroidectomized and hypophysectomized rats given tri-iodothyronine or/and growth hormone. J. Endocrinol. 142: 77-84.
152. RICHARDSON, S.J. et al. 2005. Developmentally regulated thyroid hormone distributor proteins in marsupials, a reptile, and fish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R1264-R1272.
153. FRANKLYN, J.A. et al. 1987. Effect of hypothyroidism and thyroid hormone replacement in vivo on pituitary cytoplasmic concentrations of thyrotropin-β and alpha-subunit messenger ribonucleic acids. Endocrinology 120: 2279-2288.
154. MIRELL, C.J. et al. 1987. Influence of thyroidal status on pituitary content of thyrotropin β- and alpha-subunit, growth hormone, and prolactin messenger ribonucleic acids. Mol. Endocrinol. 1: 408-412.
155. SHUPNIK, M.A. & E.C. RIDGWAY. 1987. Thyroid hormone control of thyrotropin gene expression in rat anterior pituitary cells. Endocrinology 121: 619-624.
156. ZOELLER, R.T., R.S. WOLFF & K.J. KOLLER. 1988. Thyroid hormone regulation of messenger ribonucleic acid encoding thyrotropin (TSH)-releasing hormone is independent of the pituitary gland and TSH. Mol. Endocrinol. 2: 248-252.
157. LAGRADI, G. et al. 1997. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138: 2569-2576.
158. FEKETE, C. et al. 2000. Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting. J. Neurosci. 20: 9224-9234.
159. ROTI, E. et al. 1993. The use and misuse of thyroid hormone. Endocr. Rev. 14: 401-423.
160. CHOPRA, I.J. 1996. Nature, source, and relative significance of circulating thyroid hormones. In The Thyroid: a Fundamental and Clinical Text. L.E. Braverman & R.D. UTIGER, Eds.: 111-124. Lippincott-Raven. Philadelphia, PA.
161. ANDERSEN, S. et al. 2003. Biologic variation is important for interpretation of thyroid function tests. Thyroid 13: 1069-1078.
162. HANSEN, P.S. et al. 2004. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89: 1181-1187.
163. OPPENHEIMER, J.H. 1983. The nuclear receptor-triiodothyronine complex: relationship to thyroid hormone distribution, metabolism, and biological action. In Molecular Basis of Thyroid Hormone Action. J.H. Oppenheimer & H.H. SAMUELS, Eds.: 1-35. Academic Press. New York, NY.
164. EVERTS M.E. et al. 1994. Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology 135: 2700-2707.
165. EVERTS M.E. et al. 1994. Uptake of thyroxine in cultured anterior pituitary cells of euthyroid rats. Endocrinology 134: 2490-2497.
166. EVERTS M.E. et al. 1995. Uptake of 3,5′,5,5′- tetraiodothyroacetic acid and 3,3′,5′-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion. Endocrinology 136: 4454-4461.
167. KRAGIE, L. 1996. Membrane Iodothyronine transporters, Part II: review of protein biochemistry. Endocr. Res. 22: 95-119.
168. DOCTER, R. et al. 1997. Expression of rat liver cell membrane transporters for thyroid hormone in Xenopus laevis oocytes. Endocrinology 138: 1841-1846.
169. MOREAU, X., P.J. LEJEUNE & R. JEANNINGROS. 1999. Kinetics of red blood cell T3 uptake in hypothyroidism with or without hormonal replacement, in the rat. J. Endocrinol. Invest. 22: 257-261.
170. FRIESEMA, E.C.H. et al. 1999. Identification of thyroid hormone transporters. Biochem. Biophys. Res. Commun. 254: 497-501.
171. HOOD, A. & C.D. KLAASSEN. 2000. Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation. Toxicol. Sci. 55: 78-84.
172. HOOD, A. & C.D. KLAASSEN. 2000. Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues. Toxicol. Appl. Pharmacol. 163: 240-248.
173. LAZAR, M.A. 1993. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr. Rev. 14: 184-193.
174. LAZAR, M.A. 1994. Thyroid hormone receptors: update 1994. Endocr. Rev. Monogr. 3: 280-283.
175. OPPENHEIMER, J.H., H.L. SCHWARTZ & K.A. STRAIT. 1994. Thyroid hormone action 1994: the plot thickens. Eur. J. Endocrinol. 130: 15-24.
176. MANGELSDORF, D.J. & R.M. EVANS. 1995. The RXR heterodimers and orphan receptors. Cell 83: 841-850.
177. OPPENHEIMER, J.H. & H.L. SCHWARTZ. 1997. Molecular basis of thyroid hormone-dependent brain development. Endocr. Rev. 18: 462-475.
178. FRIESEMA, E.C. et al. 2005. Thyroid hormone transporters. Vitam. Horm. 70: 137-167.
179. ALKEMADE, A. et al. 2006. Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. Eur. J. Endocrinol. 154: 491-500.